HALO logo

Halozyme Therapeutics (HALO) Inventory

annual inventory:

$141.86M+$14.26M(+11.17%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual inventory is $141.86 million, with the most recent change of +$14.26 million (+11.17%) on December 31, 2024.
  • During the last 3 years, HALO annual inventory has risen by +$87.95 million (+163.15%).
  • HALO annual inventory is now at all-time high.

Performance

HALO Inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

quarterly inventory:

$164.87M+$23.01M(+16.22%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly inventory is $164.87 million, with the most recent change of +$23.01 million (+16.22%) on March 31, 2025.
  • Over the past year, HALO quarterly inventory has dropped by -$3.67 million (-2.18%).
  • HALO quarterly inventory is now -2.18% below its all-time high of $168.54 million, reached on March 31, 2024.

Performance

HALO quarterly inventory Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Inventory Formula

Inventory = Beginning Inventory + Purchases − Cost of Goods Sold

HALO Inventory Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.2%-2.2%
3 y3 years+163.2%+245.2%
5 y5 years+383.2%+297.7%

HALO Inventory Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+163.2%-2.2%+245.2%
5 y5-yearat high+383.2%-2.2%+297.7%
alltimeall timeat high>+9999.0%-2.2%>+9999.0%

HALO Inventory History

DateAnnualQuarterly
Mar 2025
-
$164.87M(+16.2%)
Dec 2024
$141.86M(+11.2%)
$141.86M(+8.0%)
Sep 2024
-
$131.41M(-17.5%)
Jun 2024
-
$159.31M(-5.5%)
Mar 2024
-
$168.54M(+32.1%)
Dec 2023
$127.60M(+27.4%)
$127.60M(-1.0%)
Sep 2023
-
$128.92M(-2.6%)
Jun 2023
-
$132.41M(+23.1%)
Mar 2023
-
$107.52M(+7.4%)
Dec 2022
$100.12M(+85.7%)
$100.12M(-3.1%)
Sep 2022
-
$103.28M(+5.8%)
Jun 2022
-
$97.61M(+104.4%)
Mar 2022
-
$47.76M(-11.4%)
Dec 2021
$53.91M(-11.3%)
$53.91M(-3.7%)
Sep 2021
-
$55.98M(-4.4%)
Jun 2021
-
$58.55M(+0.4%)
Mar 2021
-
$58.34M(-4.0%)
Dec 2020
$60.75M(+106.9%)
$60.75M(+5.3%)
Sep 2020
-
$57.70M(+19.5%)
Jun 2020
-
$48.27M(+16.5%)
Mar 2020
-
$41.45M(+41.2%)
Dec 2019
$29.36M(+29.8%)
$29.36M(-18.6%)
Sep 2019
-
$36.05M(-17.9%)
Jun 2019
-
$43.90M(+40.5%)
Mar 2019
-
$31.24M(+38.1%)
Dec 2018
$22.63M(+339.7%)
$22.63M(+23.7%)
Sep 2018
-
$18.29M(+117.6%)
Jun 2018
-
$8.40M(+91.3%)
Mar 2018
-
$4.39M(-14.6%)
Dec 2017
$5.15M(-64.8%)
$5.15M(-44.9%)
Sep 2017
-
$9.33M(-38.5%)
Jun 2017
-
$15.17M(+6.2%)
Mar 2017
-
$14.29M(-2.3%)
Dec 2016
$14.62M(+54.1%)
$14.62M(+13.8%)
Sep 2016
-
$12.85M(+19.5%)
Jun 2016
-
$10.76M(+4.0%)
Mar 2016
-
$10.35M(+9.0%)
Dec 2015
$9.49M(+48.1%)
$9.49M(-14.5%)
Sep 2015
-
$11.10M(+43.7%)
Jun 2015
-
$7.72M(+3.2%)
Mar 2015
-
$7.48M(+16.8%)
DateAnnualQuarterly
Dec 2014
$6.41M(+3.8%)
$6.41M(-7.4%)
Sep 2014
-
$6.92M(-2.8%)
Jun 2014
-
$7.11M(+5.2%)
Mar 2014
-
$6.76M(+9.6%)
Dec 2013
$6.17M(+131.0%)
$6.17M(+60.4%)
Sep 2013
-
$3.85M(+55.9%)
Jun 2013
-
$2.47M(-9.9%)
Mar 2013
-
$2.74M(+2.5%)
Dec 2012
$2.67M(+370.8%)
$2.67M(+22.2%)
Sep 2012
-
$2.19M(+22.5%)
Jun 2012
-
$1.78M(+19.2%)
Mar 2012
-
$1.50M(+163.8%)
Dec 2011
$567.30K(+193.3%)
$567.30K(+448.6%)
Sep 2011
-
$103.40K(+23.4%)
Jun 2011
-
$83.80K(-66.3%)
Mar 2011
-
$248.50K(+28.5%)
Dec 2010
$193.40K(-83.3%)
$193.40K(-82.0%)
Sep 2010
-
$1.08M(-0.5%)
Jun 2010
-
$1.08M(-6.7%)
Mar 2010
-
$1.16M(0.0%)
Dec 2009
$1.16M(+162.8%)
$1.16M(-6.4%)
Sep 2009
-
$1.24M(+54.1%)
Jun 2009
-
$803.50K(+41.8%)
Mar 2009
-
$566.80K(+28.4%)
Dec 2008
$441.30K(-37.3%)
$441.30K(-16.0%)
Sep 2008
-
$525.40K(-19.1%)
Jun 2008
-
$649.30K(-4.4%)
Mar 2008
-
$679.10K(-3.5%)
Dec 2007
$703.50K(+59.0%)
$703.50K(-1.4%)
Sep 2007
-
$713.30K(+15.0%)
Jun 2007
-
$620.30K(+30.5%)
Mar 2007
-
$475.20K(+7.4%)
Dec 2006
$442.50K(+58.6%)
$442.50K(+89.3%)
Sep 2006
-
$233.80K(-43.5%)
Jun 2006
-
$414.10K(+44.7%)
Mar 2006
-
$286.20K(+2.6%)
Dec 2005
$279.00K(+438.6%)
$279.00K(+514.5%)
Sep 2005
-
$45.40K(+46.0%)
Jun 2005
-
$31.10K(-34.0%)
Mar 2005
-
$47.10K(-9.1%)
Dec 2004
$51.80K
$51.80K

FAQ

  • What is Halozyme Therapeutics annual inventory?
  • What is the all time high annual inventory for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual inventory year-on-year change?
  • What is Halozyme Therapeutics quarterly inventory?
  • What is the all time high quarterly inventory for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly inventory year-on-year change?

What is Halozyme Therapeutics annual inventory?

The current annual inventory of HALO is $141.86M

What is the all time high annual inventory for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual inventory is $141.86M

What is Halozyme Therapeutics annual inventory year-on-year change?

Over the past year, HALO annual inventory has changed by +$14.26M (+11.17%)

What is Halozyme Therapeutics quarterly inventory?

The current quarterly inventory of HALO is $164.87M

What is the all time high quarterly inventory for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly inventory is $168.54M

What is Halozyme Therapeutics quarterly inventory year-on-year change?

Over the past year, HALO quarterly inventory has changed by -$3.67M (-2.18%)
On this page